Citations

Mayo Clinic

Clear

989 citation(s) found for "Vu-Han, TL".

Automated Droplet-Based Microfluidic Platform for Multiplexed Analysis of Biochemical Markers in Small Volumes
Cedillo‐Alcantar, Diana F. , Han, Yong Duk, García-Cordero, José L. , Revzin, Alexander , Choi, Jonghoon, Garcia-Cordero, Jose L , Revzin, Alexander , Choi, Jonghoon

Analytical Chemistry | March 5, 2019 | Volume: 91 | Issue: 8 | Pages: 5133-5141

10.1021/acs.analchem.8b05689 | PMID 30834743 Get It

A Proposal to Add a New Dedicated Chapter in ICD-11: Disorders Related to Chronic Pain
Cheng, Jianguo , Han, Ji-Sheng, Gallagher, Rollin M., Fan, Bifa , Liu, Yanqing , Stanos, Steven P., Lamer, Tim J. , Zhang, Daying , Fu, Zhijian , Yi, Xiaobin , Liu, Xiaoli , Ma, Ke , Jin, Yi, Yang, Xiao-Qiu, Huang, Dong , Xiao, Lizu, Feng, Zhi-Ying, Cheng, Zhixiang , Lü, Yan , Song, Xue‐Jun , Yu, Shengyuan , Jin, Yi, Feng, Zhi-Ying

Pain Medicine | February 27, 2019 | Volume: 21 | Issue: 3 | Pages: 436-438

10.1093/pm/pnz060 | PMID 30953586 Get It

Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions
Bastea, Ligia I. , Liou, Geou‐Yarh , Pandey, Veethika , Martinez, Alicia K. Fleming , Roemeling, Christina A. Von , Doeppler, Heike, Qiu, Yushi, Edenfield, Brandy , Copland, John A. , Störz, Peter , Fleming, Alicia K, von Roemeling, Christina A , Tun, Han W. , Liou, Geou-Yarh , Bastea, Ligia , Döppler, Heike, Li, Zhimin

Cancer Research | January 29, 2019 | Volume: 79 | Issue: 7 | Pages: 1535-1548

10.1158/0008-5472.can-18-1153 | PMID 30696657 Get It

Abstract During development of pancreatic cancer, alternatively activated macrophages contribute to fibrogenesis, pancreatic intraepithelial neoplasia (PanIN) lesion growth, and generation of an immunosuppressive environment. Here, we show that the immunomodulatory agent pomalidomide depletes pancreatic lesion areas of alternatively activated macrophage populations. Pomalidomide treatment resulted in downregulation of interferon regulatory factor 4, a transcription factor for M2 macrophage polarization. Pomalidomide-induced absence of alternatively activated macrophages led to a decrease in fibrosis at PanIN lesions and in syngeneic tumors; this was due to generation of an inflammatory, immune-responsive environment with increased expression of IL1α and presence of activated (IFNγ-positive) CD4+ and CD8+ T-cell populations. Our results indicate that pomalidomide could be used to decrease fibrogenesis in pancreatic cancer and may be ideal as a combination treatment with chemotherapeutic drugs or other immunotherapies. Significance: These findings reveal new insights into how macrophage populations within the pancreatic cancer microenvironment can be modulated, providing the means to turn the microenvironment from immunosuppressive to immune-responsive.
Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes
Binzer-Panchal, Amrei , Hardell, Elin, Viklund, Björn, Ghaderi, Mehran , Bosse, Tjalling , Nucci, Marisa R. , Hollfelder, Nina , Corcoran, Pádraic, Gonzalez‐Molina, Jordi , Moyano‐Galceran, Lidia , Bell, Debra A., Schoolmeester, John K., Måsbäck, Anna , Kristensen, Gunnar B. , Davidson, Ben , Lehti, Kaisa , Carlson, Joseph W. , Hollfelder, Nina , Gonzalez-Molina, Jordi , Kristensen, Gunnar B , Lehti, Kaisa , Carlson, Joseph W , Lee, Cheng‐Han , Isaksson, Anders

Clinical Cancer Research | January 7, 2019 | Volume: 25 | Issue: 7 | Pages: 2155-2165

10.1158/1078-0432.ccr-18-2792 | PMID 30617134 Get It

Abstract Purpose: Undifferentiated uterine sarcomas (UUS) are rare, extremely deadly, sarcomas with no effective treatment. The goal of this study was to identify novel intrinsic molecular UUS subtypes using integrated clinical, histopathologic, and molecular evaluation of a large, fully annotated, patient cohort. Experimental Design: Fifty cases of UUS with full clinicopathologic annotation were analyzed for gene expression (n = 50), copy-number variation (CNV, n = 40), cell morphometry (n = 39), and protein expression (n = 22). Gene ontology and network enrichment analysis were used to relate over- and underexpressed genes to pathways and further to clinicopathologic and phenotypic findings. Results: Gene expression identified four distinct groups of tumors, which varied in their clinicopathologic parameters. Gene ontology analysis revealed differential activation of pathways related to genital tract development, extracellular matrix (ECM), muscle function, and proliferation. A multivariable, adjusted Cox proportional hazard model demonstrated that RNA group, mitotic index, and hormone receptor expression influence patient overall survival (OS). CNV arrays revealed characteristic chromosomal changes for each group. Morphometry demonstrated that the ECM group, the most aggressive, exhibited a decreased cell density and increased nuclear area. A cell density cutoff of 4,300 tumor cells per mm2 could separate ECM tumors from the remaining cases with a sensitivity of 83% and a specificity of 94%. IHC staining of MMP-14, Collagens 1 and 6, and Fibronectin proteins revealed differential expression of these ECM-related proteins, identifying potential new biomarkers for this aggressive sarcoma subgroup. Conclusions: Molecular evaluation of UUS provides novel insights into the biology, prognosis, phenotype, and possible treatment of these tumors.
Perceptions of radiation oncologists and urologists about new technology for the treatment of prostate cancer.
Han, Leona C., Shah, Nilay D. , Gross, Cary P. , Smaldone, Marc C., Tilburt, Jon C. , Trinh, Q.D., Karnes, R. Jeffrey , Ranasinghe, Weranja Kalana Bodhisiri, Sun, Maxine , Kim, Simon P. , Ranasinghe, Weranja , Ross, Joseph S. , Nguyen, Paul L. , Yu, James B.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: e16085-e16085

10.1200/jco.2014.32.15_suppl.e16085 Get It

Out-of-pockets costs for patients receiving targeted agents for metastatic renal cell carcinoma.
Kim, Simon P. , Gross, Cary P. , Abouassaly, Robert , Houten, Holly K. Van , Thompson, R. Houston, Smaldone, Marc C., Trinh, Q.D., Sun, Maxine , Han, Leona C., Shah, Nilay D. , Psutka, Sarah P.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: e15598-e15598

10.1200/jco.2014.32.15_suppl.e15598 Get It

Clinical utility of tumor measurement (TM)-based metrics in phase II (P2) to predict phase III (P3) overall survival (OS) outcomes using the RECIST 1.1 database.
Mandrekar, Sumithra J. , An, Ming‐Wen , Han, Yu , Group, RECIST Working, Sargent, Daniel J. , Group, RECIST Working

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 6600-6600

10.1200/jco.2014.32.15_suppl.6600 Get It

Prognostic associations of 25OH vitamin D in NCIC CTG MA.21, a phase III adjuvant RCT of three chemotherapy regimens (EC/T, CEF, AC/T) in high-risk breast cancer (BC).
Chapman, Judy‐Anne W., Burnell, Margot J., Levine, Mark N. , O’Brien, Patti, Han, Lei , Albain, Kathy S. , Perez, Edith A. , Vandenberg, Theodore A. , Chalchal, Haji , Sawhney, Ravinder, Shepherd, Lois E. , Lohmann, Ana Elisa , Tsvetkova, Elena V. , Pritchard, Kathleen I. , Gelmon, Karen A. , Rugo, Hope S. , Goodwin, Pamela J.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 504-504

10.1200/jco.2014.32.15_suppl.504 Get It

Novel zebrafish behavioral assay to identify modifiers of the rapid, nongenomic stress response
Lee, Han , Schwab, Tanya L., Sigafoos, Ashley N. , Gauerke, Jennifer L., Krug, Randall G. , Serres, MaKayla R., Jacobs, Dakota C., Cotter, Ryan P. , Das, Biswadeep , Petersen, Morgan O. , Daby, Camden L. , Urban, Rhianna , Berry, Bethany C. , Lee, Han B , Urban, Rhianna M, Clark, Karl J , Serres, MaKayla R., Clark, Karl J. , Cotter, Ryan P

Genes, Brain and Behavior | December 27, 2018 | Volume: 18 | Issue: 2 | Pages: No page available

10.1111/gbb.12549 | PMID 30588759 Get It

When vertebrates face acute stressors, their bodies rapidly undergo a repertoire of physiological and behavioral adaptations, which is termed the stress response. Rapid changes in heart rate and blood glucose levels occur via the interaction of glucocorticoids and their cognate receptors following hypothalamic‐pituitary‐adrenal axis activation. These physiological changes are observed within minutes of encountering a stressor and the rapid time domain rules out genomic responses that require gene expression changes. Although behavioral changes corresponding to physiological changes are commonly observed, it is not clearly understood to what extent hypothalamic‐pituitary‐adrenal axis activation dictates adaptive behavior. We hypothesized that rapid locomotor response to acute stressors in zebrafish requires hypothalamic‐pituitary‐interrenal (HPI) axis activation. In teleost fish, interrenal cells are functionally homologous to the adrenocortical layer. We derived eight frameshift mutants in genes involved in HPI axis function: two mutants in exon 2 ofmc2r(adrenocorticotropic hormone receptor), five in exon 2 or 5 ofnr3c1(glucocorticoid receptor [GR]) and two in exon 2 ofnr3c2(mineralocorticoid receptor [MR]). Exposing larval zebrafish to mild environmental stressors, acute changes in salinity or light illumination, results in a rapid locomotor response. We show that this locomotor response requires a functioning HPI axis via the action ofmc2rand the canonical GR encoded bynr3c1gene, but not MR (nr3c2). Our rapid behavioral assay paradigm based on HPI axis biology can be used to screen for genetic and environmental modifiers of the hypothalamic‐pituitary‐adrenal axis and to investigate the effects of corticosteroids and their cognate receptor interactions on behavior.
A concise and persistent feature to study brain resting‐state network dynamics: Findings from the Alzheimer's Disease Neuroimaging Initiative
Kuang, Liqun , Han, Xie , Chen, Kewei , Caselli, Richard J. , Reiman, Eric M. , Wang, Yalin , Initiative, for the Alzheimer's Disease Neuroimaging, Jack, Clifford R. , Levey, Allan I. , Kantarci, Kejal , Mathis, Chester A. , Donohue, Michael , DeCarli, Charles , Preda, Adrian , Carrillo, María C. , Turner, Raymond Scott , Bartha, Robert , Pomara, Nunzio , Sadowski, Martin , Arfanakis, Konstantinos , Lamar, Melissa , DeCarli, Charles , Jack, Clifford R , Preda, Adrian , Kantarci, Kejal , Donohue, Michael C , Initiative, for the Alzheimer's Disease Neuroimaging, Wang, Yalin , Levey, Allan I

Human Brain Mapping | December 20, 2018 | Volume: 40 | Issue: 4 | Pages: 1062-1081

10.1002/hbm.24383 | PMID 30569583 Get It

AbstractAlzheimer's disease (AD) is the most common type of dementia in the elderly with no effective treatment currently. Recent studies of noninvasive neuroimaging, resting‐state functional magnetic resonance imaging (rs‐fMRI) with graph theoretical analysis have shown that patients with AD and mild cognitive impairment (MCI) exhibit disrupted topological organization in large‐scale brain networks. In previous work, it is a common practice to threshold such networks. However, it is not only difficult to make a principled choice of threshold values, but also worse is the discard of potential important information. To address this issue, we propose a threshold‐free feature by integrating a prior persistent homology‐based topological feature (the zeroth Betti number) and a newly defined connected component aggregation cost feature to model brain networks over all possible scales. We show that the induced topological feature (Integrated Persistent Feature) follows a monotonically decreasing convergence function and further propose to use its slope as a concise and persistent brain network topological measure. We apply this measure to study rs‐fMRI data from the Alzheimer's Disease Neuroimaging Initiative and compare our approach with five other widely used graph measures across five parcellation schemes ranging from 90 to 1,024 region‐of‐interests. The experimental results demonstrate that the proposed network measure shows more statistical power and stronger robustness in group difference studies in that the absolute values of the proposed measure of AD are lower than MCI and much lower than normal controls, providing empirical evidence for decreased functional integration in AD dementia and MCI.